Table 1. Patients' baseline characteristics.
| Patient characteristics | |
|---|---|
| Total number of patients | 25 |
| Race | |
| Caucasian | 25 |
| Age (years) | |
| Median | 73 |
| Mean | 67 |
| Range | 48–82 |
| ECOG performance status | |
| 0 | 8 |
| 1 | 15 |
| 2 | 2 |
| Disease location | |
| Bone only | 13 |
| Nodal only | 4 |
| Bone and nodal | 8 |
| Gleason score | |
| 5 | 1 |
| 6 | 2 |
| 7 | 10 |
| 8 | 3 |
| 9 | 9 |
| Median | 7 |
| PSA, ng/mL | |
| Median | 186 |
| Mean | 245 |
| Range | 1–749 |
| Lactate dehydrogenase, IU/L | |
| Median | 234 |
| Mean | 248 |
| Range | 129–399 |
| Alkaline phosphatase, IU/L | |
| Median | 192 |
| Mean | 327 |
| Range | 37–1843 |
| Hemoglobin, g/dL | |
| Median | 11, 9 |
| Mean | 11, 9 |
| Range | 9–14, 8 |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; PSA, prostate specific antigen.